wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48092147-9EE117E1-5CDA-4BC8-A714-44141F19199F
Q48092147-9EE117E1-5CDA-4BC8-A714-44141F19199F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48092147-9EE117E1-5CDA-4BC8-A714-44141F19199F
Clinical trials of biosimilars should become more similar.
P2860
Q48092147-9EE117E1-5CDA-4BC8-A714-44141F19199F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48092147-9EE117E1-5CDA-4BC8-A714-44141F19199F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff2c4e3f6b45b6ea717bb6bc3be1e543722b7d92
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.